Innovating Viral Vector Production Platforms for Gene Therapy Applications
Gene therapy has been around for over decades, and its potential serves as a silver lining to many people with genetic diseases and different types of cancer.The main advantage of gene therapy that outweighs its disadvantages is the promise of providing patients a life free of regular therapies and disease management.
With the aim of improving more lives, Esco offers a series of viral vector CDMO services for early-stage gene therapy research, preclinical phase trial, clinical phase trial, and commercial manufacturing.Our top priority is to use our expertise and streamline our platform processes to meet your specific needs.
-
Cell Preparation and Thawing
-
Upstream Bioprocessing (Cell Seeding, Culture, Expansion and Harvest)
-
Downstream Bioprocessing and Quality Controls
-
Formulation and Filling
-
Labeling and Packaging
-
Storage
